Dr. Soly Melamed Sr., MD

Dr. Melamed practices at Beverly Hills Endosurgical Center in Beverly Hills, California.

Dr. Melamed's NPI, 1619031697, was assigned on December 21, 2006. Dr. Melamed graduated from Other in 1953. Dr. Melamed holds California license A36708.

Dr. Melamed's primary practice is Beverly Hills Endosurgical Center, at 150 North Robertson Blvd, Suite 110, Beverly Hills, CA 90211. The practice phone is (323) 202-2023.

Dr. Melamed's primary practice is Beverly Hills Endosurgical Center in Beverly Hills, California. The medical group on file is Beverly Hills Internal Medicine. Dmand AI also links Dr. Melamed to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melamed practices, 4 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Melamed's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Melamed is licensed in California.

Dmand AI lists acid reflux, bronchitis, chronic diabetes, chronic obstructive pulmonary disease (COPD), contact dermatitis, coronary artery disease, depression and diabetic emergency among the conditions Dr. Melamed treats.

CMS data shows 122 Medicare services from Dr. Melamed across 4 procedure codes in 2024, for 67 Medicare patients. Medicare paid $10,132 for them. Every service was in an office.

CMS counts 67 Medicare patients who saw Dr. Melamed in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 31% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Melamed's median patient age at 73, with 43% women.

In 2024, Dr. Melamed wrote 223 Medicare Part D claims for 40 patients. 84% of them were for generic drugs. CMS names the drug for 66 of them, across 5 drugs with 11 or more claims each, at $16,336 in total drug cost. In 2023, CMS named 151 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Melamed for performance year 2024, reported as part of a group. Dr. Melamed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 27 general payments to Dr. Melamed from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $119.

Dr. Melamed graduated from Other in 1953.

Dr. Melamed is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.